

Currently released so far... 12900 / 251,287
Browse latest releases
2010/12/01
2010/12/02
2010/12/03
2010/12/04
2010/12/05
2010/12/06
2010/12/07
2010/12/08
2010/12/09
2010/12/10
2010/12/11
2010/12/12
2010/12/13
2010/12/14
2010/12/15
2010/12/16
2010/12/17
2010/12/18
2010/12/19
2010/12/20
2010/12/21
2010/12/22
2010/12/23
2010/12/24
2010/12/25
2010/12/26
2010/12/27
2010/12/28
2010/12/29
2010/12/30
2011/01/01
2011/01/02
2011/01/04
2011/01/05
2011/01/07
2011/01/09
2011/01/10
2011/01/11
2011/01/12
2011/01/13
2011/01/14
2011/01/15
2011/01/16
2011/01/17
2011/01/18
2011/01/19
2011/01/20
2011/01/21
2011/01/22
2011/01/23
2011/01/24
2011/01/25
2011/01/26
2011/01/27
2011/01/28
2011/01/29
2011/01/30
2011/01/31
2011/02/01
2011/02/02
2011/02/03
2011/02/04
2011/02/05
2011/02/06
2011/02/07
2011/02/08
2011/02/09
2011/02/10
2011/02/11
2011/02/12
2011/02/13
2011/02/14
2011/02/15
2011/02/16
2011/02/17
2011/02/18
2011/02/19
2011/02/20
2011/02/21
2011/02/22
2011/02/23
2011/02/24
2011/02/25
2011/02/26
2011/02/27
2011/02/28
2011/03/01
2011/03/02
2011/03/03
2011/03/04
2011/03/05
2011/03/06
2011/03/07
2011/03/08
2011/03/09
2011/03/10
2011/03/11
2011/03/13
2011/03/14
2011/03/15
2011/03/16
2011/03/17
2011/03/18
2011/03/19
2011/03/20
2011/03/21
2011/03/22
2011/03/23
2011/03/24
2011/03/25
2011/03/26
2011/03/27
2011/03/28
2011/03/29
2011/03/30
2011/03/31
2011/04/01
2011/04/02
2011/04/03
2011/04/04
2011/04/05
2011/04/06
2011/04/07
2011/04/08
2011/04/09
2011/04/10
2011/04/11
2011/04/12
2011/04/13
2011/04/14
2011/04/15
2011/04/16
2011/04/17
2011/04/18
2011/04/19
2011/04/20
2011/04/21
2011/04/22
2011/04/23
2011/04/24
2011/04/25
2011/04/26
2011/04/27
2011/04/28
2011/04/29
2011/04/30
2011/05/01
2011/05/02
2011/05/03
2011/05/04
2011/05/05
2011/05/06
2011/05/07
2011/05/08
2011/05/09
2011/05/10
2011/05/11
2011/05/12
2011/05/13
2011/05/14
2011/05/15
2011/05/16
2011/05/17
2011/05/18
2011/05/19
2011/05/20
2011/05/21
2011/05/22
2011/05/23
2011/05/24
Browse by creation date
Browse by origin
Embassy Athens
Embassy Asuncion
Embassy Astana
Embassy Asmara
Embassy Ashgabat
Embassy Apia
Embassy Ankara
Embassy Amman
Embassy Algiers
Embassy Addis Ababa
Embassy Accra
Embassy Abuja
Embassy Abu Dhabi
Embassy Abidjan
Consulate Auckland
Consulate Amsterdam
Consulate Adana
American Institute Taiwan, Taipei
Embassy Bujumbura
Embassy Buenos Aires
Embassy Budapest
Embassy Bucharest
Embassy Brussels
Embassy Bridgetown
Embassy Bratislava
Embassy Brasilia
Embassy Bogota
Embassy Bishkek
Embassy Bern
Embassy Berlin
Embassy Belmopan
Embassy Belgrade
Embassy Beirut
Embassy Beijing
Embassy Banjul
Embassy Bangkok
Embassy Bandar Seri Begawan
Embassy Bamako
Embassy Baku
Embassy Baghdad
Consulate Barcelona
Embassy Copenhagen
Embassy Conakry
Embassy Colombo
Embassy Chisinau
Embassy Caracas
Embassy Canberra
Embassy Cairo
Consulate Curacao
Consulate Ciudad Juarez
Consulate Chennai
Consulate Casablanca
Consulate Cape Town
Consulate Calgary
Embassy Dushanbe
Embassy Dublin
Embassy Doha
Embassy Djibouti
Embassy Dili
Embassy Dhaka
Embassy Dar Es Salaam
Embassy Damascus
Embassy Dakar
Consulate Dubai
Embassy Helsinki
Embassy Harare
Embassy Hanoi
Consulate Ho Chi Minh City
Consulate Hermosillo
Consulate Hamilton
Consulate Hamburg
Consulate Halifax
Embassy Kyiv
Embassy Kuwait
Embassy Kuala Lumpur
Embassy Kinshasa
Embassy Kingston
Embassy Kigali
Embassy Khartoum
Embassy Kathmandu
Embassy Kampala
Embassy Kabul
Consulate Kolkata
Consulate Karachi
Embassy Luxembourg
Embassy Luanda
Embassy London
Embassy Ljubljana
Embassy Lisbon
Embassy Lima
Embassy Lilongwe
Embassy La Paz
Consulate Lahore
Consulate Lagos
Mission USOSCE
Mission USNATO
Mission UNESCO
Embassy Muscat
Embassy Moscow
Embassy Montevideo
Embassy Monrovia
Embassy Minsk
Embassy Mexico
Embassy Mbabane
Embassy Maputo
Embassy Manila
Embassy Manama
Embassy Managua
Embassy Malabo
Embassy Madrid
Consulate Munich
Consulate Mumbai
Consulate Montreal
Consulate Monterrey
Consulate Milan
Consulate Melbourne
Embassy Nicosia
Embassy Niamey
Embassy New Delhi
Embassy Ndjamena
Embassy Nassau
Embassy Nairobi
Consulate Naples
Consulate Naha
Embassy Pristina
Embassy Pretoria
Embassy Prague
Embassy Port Of Spain
Embassy Port Louis
Embassy Port Au Prince
Embassy Phnom Penh
Embassy Paris
Embassy Paramaribo
Embassy Panama
Consulate Peshawar
REO Basrah
Embassy Rome
Embassy Riyadh
Embassy Riga
Embassy Reykjavik
Embassy Rangoon
Embassy Rabat
Consulate Rio De Janeiro
Consulate Recife
Secretary of State
Embassy Suva
Embassy Stockholm
Embassy Sofia
Embassy Skopje
Embassy Singapore
Embassy Seoul
Embassy Sarajevo
Embassy Santo Domingo
Embassy Santiago
Embassy Sanaa
Embassy San Salvador
Embassy San Jose
Consulate Strasbourg
Consulate St Petersburg
Consulate Shenyang
Consulate Shanghai
Consulate Sapporo
Consulate Sao Paulo
Embassy Tunis
Embassy Tripoli
Embassy Tokyo
Embassy The Hague
Embassy Tel Aviv
Embassy Tehran
Embassy Tegucigalpa
Embassy Tbilisi
Embassy Tashkent
Embassy Tallinn
Consulate Toronto
Consulate Tijuana
USUN New York
USEU Brussels
US Office Almaty
US Mission Geneva
US Interests Section Havana
US Delegation, Secretary
UNVIE
Embassy Ulaanbaatar
Embassy Vilnius
Embassy Vienna
Embassy Vatican
Embassy Valletta
Consulate Vladivostok
Consulate Vancouver
Browse by tag
AE
ASEC
AS
AR
AMGT
AFIN
AORC
AU
AG
AF
APER
ABLD
ADCO
ABUD
AM
AID
AJ
AEMR
AMED
AL
ASUP
AN
AIT
ACOA
ANET
ASIG
AA
AGMT
AINF
AFFAIRS
ADANA
AY
AADP
ARF
ACS
AGR
AMCHAMS
AECL
AUC
APEC
APECO
AFGHANISTAN
ACAO
ASEAN
ADM
AGAO
AND
ADPM
ATRN
ALOW
AROC
APCS
AORG
AO
AODE
ACABQ
AX
AMEX
AZ
ARM
AQ
ATFN
AMBASSADOR
ACBAQ
AFSI
AFSN
AC
ASEX
AER
AVERY
AGRICULTURE
ASCH
AFU
AMG
ATPDEA
ASECKFRDCVISKIRFPHUMSMIGEG
AORL
BR
BO
BA
BM
BL
BH
BK
BEXP
BILAT
BTIO
BF
BU
BD
BY
BE
BG
BB
BBSR
BT
BRUSSELS
BP
BX
BC
BIDEN
BMGT
BWC
BN
BTIU
CA
CS
CO
CD
CR
CPAS
CDG
CI
CDC
CBW
CU
CVIS
CE
CONS
CH
CMGT
CASC
CY
CW
CG
CJAN
CIDA
CODEL
CWC
CIA
CBSA
CEUDA
CFED
CLINTON
CAC
CL
CACS
CIC
CHR
CAPC
CM
CT
CTR
COM
CROS
CN
COPUOS
CV
CF
CARSON
CONDOLEEZZA
CICTE
CYPRUS
COUNTER
COUNTRY
CBE
CKGR
CVR
COUNTERTERRORISM
CITEL
CLEARANCE
COE
CARICOM
CB
CSW
CITT
CACM
CDB
CJUS
CTM
CAN
CLMT
CBC
CNARC
CIS
EFIN
ECON
ETRD
EAID
EC
EU
EUN
EINV
EG
ETTC
EIND
ELAB
EAGR
ECIN
EINT
ENRG
EFIS
ELTN
EAIR
EPET
EZ
ET
ENERG
ECPS
EWWT
EI
ETRN
EINVECONSENVCSJA
EEPET
EUNCH
ER
ES
EN
EMIN
ESENV
ENNP
ENGR
ETRDEINVECINPGOVCS
ENVI
ECINECONCS
ELN
EFTA
ELECTIONS
ENVR
EXTERNAL
ENIV
ESA
EPA
ETRO
ETRDECONWTOCS
EUR
ECUN
EXIM
EK
EUREM
ECONOMY
EUMEM
ERNG
EFINECONCS
EAIDS
ECA
ETRC
EINVEFIN
ETC
EAP
EINN
ECONOMIC
EXBS
ENGY
ECONOMICS
EIAR
EINDETRD
ECONEFIN
EURN
EDU
ETRDEINVTINTCS
ECIP
EFIM
EREL
EINVETC
ECONCS
ETRA
EAIG
EUC
ERD
IQ
IR
IS
IN
IA
IC
IZ
ICRC
ID
IDA
IT
IO
IAEA
ICJ
ICAO
IV
IBRD
IMF
IAHRC
IWC
ILO
ISLAMISTS
IGAD
ILC
ITU
ITF
INRA
INRO
ICTY
INRB
ITALY
IBET
IL
INTELSAT
ISRAELI
IMO
IDP
ICTR
ITRA
IRC
IRAQI
IEFIN
IPR
IIP
INMARSAT
ITPGOV
ITALIAN
INTERNAL
IRS
INTERPOL
IEA
INR
ISRAEL
IZPREL
IRAJ
IF
ITPHUM
IACI
INDO
KPAO
KMDR
KCOR
KNNP
KJUS
KCRM
KDEM
KVPR
KTFN
KPRP
KTIP
KSCA
KSUM
KTEX
KIDE
KIRF
KV
KTIA
KN
KG
KFRD
KWMN
KUNR
KISL
KU
KGHG
KPKO
KOMS
KPAL
KIPR
KMCA
KOMC
KRVC
KSEP
KAWC
KOLY
KWBG
KACT
KFLO
KHIV
KZ
KGIC
KBCT
KDRG
KBTR
KCFE
KE
KHLS
KMPI
KAWK
KPWR
KIRC
KRAD
KFRDCVISCMGTCASCKOCIASECPHUMSMIGEG
KFLU
KPLS
KRIM
KSTH
KDDG
KPRV
KICC
KS
KSAF
KBIO
KREC
KCGC
KCIP
KTDB
KWAC
KPAI
KFRDKIRFCVISCMGTKOCIASECPHUMSMIGEG
KFSC
KSTC
KMFO
KID
KNAR
KMIG
KVRP
KNEI
KGIT
KNSD
KHDP
KSAC
KWMM
KR
KCOM
KAID
KENV
KVIR
KHSA
KO
KCRS
KPOA
KTER
KFIN
KSPR
KTBT
KX
KCMR
KMOC
KCRCM
KBTS
KSEO
KOCI
KNUP
KPAONZ
KNUC
KNNPMNUC
KERG
KSCI
KTLA
KCSY
KTRD
KMRS
KNPP
KJUST
KRCM
KCFC
KCHG
KREL
KFTFN
KLIG
KDEMAF
KGCC
KICA
KHUM
KSEC
KPIN
KESS
KDEV
KPIR
KWWMN
KOM
KWNM
KRFD
KRGY
KIFR
KWMNCS
KPAK
MARR
MOPS
MUCN
MCAP
MNUC
MEPP
MTCRE
MASS
MO
MIL
MX
MAS
MEDIA
MAR
MI
MQADHAFI
MPOS
MTCR
MK
MG
MA
MY
MU
ML
MPS
MW
MD
MARAD
MC
MR
MT
MTRE
MASC
MRCRE
MAPP
MZ
MP
MOPPS
MTS
MLS
MILI
MEPN
MEPI
MEETINGS
MERCOSUR
MCC
MIK
MAPS
MV
MILITARY
MDC
MASSMNUC
NI
NZ
NL
NO
NPT
NATO
NS
NU
NP
NPA
NSFO
NDP
NT
NW
NASA
NSG
NE
NORAD
NAFTA
NG
NATIONAL
NSSP
NV
NSF
NK
NA
NEW
NPG
NR
NGO
NIPP
NZUS
NH
NC
NRR
NAR
NATOPREL
NSC
OIIP
OPRC
OTRA
OEXC
OREP
OSCE
OVIP
OPAD
OBSP
OECD
OFFICIALS
OAS
OPDC
ODIP
OPCW
OES
OFDP
OPIC
OCS
OIC
OHUM
OSCI
OVP
ODC
OIE
OTR
OMIG
OSAC
OFDA
ON
OCII
PREL
PINR
PGOV
PARM
PE
PTER
PHUM
PO
PINS
PREF
PK
PM
POL
PBTS
PNAT
PHSA
PAS
PA
PL
PGIV
PHUMPREL
POGOV
PAK
PEL
PROP
PP
PINL
PBT
PTBS
PG
PINF
PRL
PALESTINIAN
PSEPC
POSTS
PAHO
PHUMPGOV
PGOC
PNR
PREFA
PMIL
POLITICS
POLICY
PROV
PBIO
PREO
PAO
PDOV
PGOF
POV
PCI
PRAM
PSI
POLITICAL
PAIGH
PJUS
PARMS
PROG
PTERE
PRGOV
PORG
PS
PKFK
PSOE
PEPR
PPA
PINT
PMAR
PRELP
PNG
PFOR
PUNE
PGOVLO
PHUMBA
POLINT
PGOVE
PHALANAGE
PARTY
PDEM
PECON
PY
PLN
PHUH
PF
PHUS
PU
PARTIES
PCUL
PGGV
PSA
PGOVSMIGKCRMKWMNPHUMCVISKFRDCA
RU
RS
REGION
REACTION
REPORT
RO
RW
RCMP
RSO
RP
RM
ROOD
RFE
RICE
ROBERT
RSP
RF
RELATIONS
RIGHTS
RIGHTSPOLMIL
RUPREL
SENV
SY
SNAR
SCUL
SP
SF
SW
SOCI
SU
SMIG
SO
SA
SR
SZ
SI
SC
SEVN
SN
STEINBERG
SK
SH
SNARCS
SPCE
SARS
SNARN
SG
SL
SYRIA
SIPRS
SAARC
SNARIZ
SWE
SYR
SEN
SCRS
SAN
ST
SIPDIS
SSA
SPCVIS
SOFA
SENVKGHG
SANC
SHI
SHUM
TU
TSPA
TBIO
TS
TRGY
TINT
TPHY
TN
TW
TH
TZ
TSPL
TP
TBID
TI
TF
TD
TT
TNGD
TL
TC
THPY
TIP
TX
TV
TK
TERRORISM
TO
TRSY
TURKEY
TFIN
TAGS
TR
UK
UNSC
UNGA
UNESCO
UNHRC
UP
UN
USTR
US
UNDC
UY
UNICEF
UNDP
UNMIK
UNAUS
UNCHC
UNCSD
USOAS
UNFCYP
UG
UNIDROIT
UNO
UV
UNHCR
UNEP
USEU
UZ
UNCND
USUN
UNCHR
USNC
USPS
USAID
UE
UNVIE
UAE
UNODC
UNCHS
UNFICYP
UNDESCO
UNC
UNPUOS
Browse by classification
Community resources
courage is contagious
Viewing cable 05BRASILIA1567,
If you are new to these pages, please read an introduction on the structure of a cable as well as how to discuss them with others. See also the FAQs
Understanding cables
Every cable message consists of three parts:
- The top box shows each cables unique reference number, when and by whom it originally was sent, and what its initial classification was.
- The middle box contains the header information that is associated with the cable. It includes information about the receiver(s) as well as a general subject.
- The bottom box presents the body of the cable. The opening can contain a more specific subject, references to other cables (browse by origin to find them) or additional comment. This is followed by the main contents of the cable: a summary, a collection of specific topics and a comment section.
Discussing cables
If you find meaningful or important information in a cable, please link directly to its unique reference number. Linking to a specific paragraph in the body of a cable is also possible by copying the appropriate link (to be found at theparagraph symbol). Please mark messages for social networking services like Twitter with the hash tags #cablegate and a hash containing the reference ID e.g. #05BRASILIA1567.
Reference ID | Created | Released | Classification | Origin |
---|---|---|---|---|
05BRASILIA1567 | 2005-06-10 13:53 | 2010-12-16 06:00 | CONFIDENTIAL | Embassy Brasilia |
This record is a partial extract of the original cable. The full text of the original cable is not available.
C O N F I D E N T I A L SECTION 01 OF 03 BRASILIA 001567
SIPDIS
STATE FOR WHA/BSC, WHA/EPSC, EB/TPP, EB/IFD/OMA, AND NEA STATE PASS USTR FOR SCRONIN, BPECK, LYANG
USDOC FOR 4332/ITA/MAC/WH/OLAC/JANDERSEN/ADRISCOLL/MWAR D USDOC FOR 3134/ITA/
USCS/OIO/WH/RD/DDEVITO/EOLSON/SHUPKA TREASURY FOR NLEE/FPARODI NSC FOR SHANNON, BREIER, RENIGAR E.O. 12958:
DECL: 06/09/2015
TAGS: KIPR ETRD EAGR EFIN BR IZ WTRO IPR
REF: A) BRASILIA 1507 (NOTAL)
B) SECSTATE 103543
C) SECSTATE 103222
D) BRASILIA 1067
Classified By: Economic Officer Janice Fair, Reasons 1.4 (b) and (d)
¶1. (C) Summary. Ambassador Hugueney of Brazil's Foreign Ministry (Itamaraty) told Ambassador June 6 that U.S. pharmaceutical companies should improve their offers on pricing and/or voluntary licenses for AIDS treatment drugs so as to avoid compulsory licensing by the Ministry of Health (MoH). Hugueney believed movement in the Chamber of Deputies of legislation that would deny patentability to AIDS drugs was likely intended to provide greater leverage to the Ministry of Health in its negotiations with the pharmaceutical companies. The bill's broad political backing, he observed, makes a presidential veto unlikely should the legislation pass. On the WTO Doha Round of trade negotiations, Hugueney said Brazil will submit a "substantially improved" revised services offer the week of June 6. Hugueney expects to take up the post of Brazil's Ambassador to the WTO by late August or early September. Hugueney confirmed Brazil's plan to attend the June 21 to 22 US-EU International Conference on Iraq. End Summary.
¶2. (SBU) On June 6, Ambassador met with Clodoaldo Hugueney, Itamaraty's Under Secretary for Economic and Technological Affairs, to discuss a number of trade issues, principally, pending legislation that would render drugs to prevent and treat AIDS un-patentable, and the continuing threat of compulsory licensing facing the U.S. pharmaceutical companies Gilead Sciences, Abbott Laboratories, and Merck, Sharp & Dohme for their AIDS treatment drugs (ref A). Hugueney was accompanied by his assistant, Miguel Franco, and Otavio Brandelli, Chief of the Ministry's IPR Division. Ecouns, Commoff, and Econoff accompanied Ambassador. AIDS Drugs - Compulsory License Threat and Patent Legislation
¶3. (C) Hugueney, who had just returned from Doha negotiations in Geneva, said Itamaraty is following MoH negotiations with the pharmaceutical companies closely and described them as boiling down to issues of pricing or voluntary license/royalty payments. He noted the intense pressure the GoB is under from civil society, particularly NGOs, to issue compulsory licenses. Hugueney agreed the best outcome would be to avoid compulsory licenses, but opined that to do so would require improved offers on price or voluntary licensing from the companies. (Upon relaying this message to the companies, the Merck representative here told us his company was in the process of preparing a more detailed offer, although he did not say that it would be more forthcoming on prices. As for Gilead and Abbott, they have taken Hugueney's suggestion "under advisement.") Hugueney further advised the companies to maintain a dialog with the MoH to forestall precipitous, politically motivated action by that Ministry, and encouraged them to explain/present their proposals to a wide array of GoB interlocutors.
¶4. (C) When questioned by Ambassador on whether an agreement between the MoH and the pharmaceutical companies would effectively kill pending legislation on patentability of AIDS drugs, Hugueney demurred on a definitive response, but said he did see the two as linked. Hugueney recounted an interview on the O Globo news the prior evening in which the bill's author prefaced his statements by saying the legislation had been given renewed impetus in order to provide greater leverage to the Ministry of Health in its negotiations with the pharmaceutical companies. (Note: On June 1, the Constitution and Justice Committee of the Chamber of Deputies approved a previously dormant bill (PL22/2003) which will exclude from patentability drugs used for the prevention and treatment of AIDS, and the production processes for their manufacture; the bill will now go directly to the Senate unless a request to place the bill before the Chamber plenary is made by 51 deputies within the next five sessions. The bill's language is very general, leaving open for debate whether or not it would be retroactive, and its scope, i.e. does it cover drugs not only for treating AIDS, but also for treating any type of malady afflicting AIDS patients, is similarly unclear. End Note.)
¶5. (C) Although the Lula administration has not formally endorsed the legislation, Hugueney noted it had wide political backing in the Chamber and warned against assuming the bill would move slowly in the Senate. (Note: although the Planalto has not endorsed the bill, the Ministry of Health has publicly lobbied for its passage.) In Hugueney's view, the companies' best hope for a satisfactory outcome would be to work toward a resolution of the licensing issue with the Ministry of Health, rather than allow the legislature to set patent parameters. He underlined the importance of stopping the legislation within the Congress, admitting that political factors would prevent a presidential veto.
¶6. (C) Brandelli reported that the National Confederation of Industries (CNI) was working to mobilize the necessary number of deputies to request that the bill be considered within the Chamber plenary; if successful, this would considerably slow down the approval process -- aside from a full legislative agenda the Chamber is also currently seized with a number of scandals involving Brazilian congressmen -- and allow for a broader debate on the bill's demerits. According to Brandelli, CNI is also willing to work directly with the U.S. pharmaceutical companies to devise a strategy for dealing with the MoH's compulsory licensing threat.
¶7. (C) In a follow-up conversation with Econoff, Brandelli reiterated Hugueney's comments regarding the need for the companies to respond to MoH pricing or voluntary licensing interests saying that investment plans are welcome, but do not address the immediate issues. Gilead has been in close communication with Brandelli and he openly praised the company's proposal, which offers substantial concessions on pricing; he described Abbott's investment plan as great for 2007, but containing nothing concrete for the MoH today. Merck reps have not yet requested a meeting with Brandelli, but did speak with Foreign Minister Amorim's Economic Advisor Antonio Simoes on May 30 as part of a Brazil-U.S. Business Council delegation. When Econoff suggested to Brandelli that no pricing plan may satisfy the MoH if its overriding interest is actually licensing, he pointed out that should the companies need to pursue recourse through Brazilian courts, they will have to demonstrate their good faith efforts in the negotiations to address the MoH's underlying concerns, which the ministry has identified as reliability of supply and pricing.
¶8. (C) Brandelli suggested the companies approach the Minister of Science and Technology, Eduardo Campos, as another possible GoB ally. Despite Itamaraty's advice to engage a number of GoB interlocutors, Brandelli admitted to Econoff that an inter-ministerial working group is being sidelined in the deliberations, which are principally between the Ministry of Health and the Casa Civil, i.e., the office of the President's Chief of Staff. WTO Doha Negotiations
¶9. (C) Hugueney expressed disappointment with a lack of leadership and organization in the agriculture negotiations the week of May 30, and stressed the substantial amount of work that must be completed to formulate a "first approximation" by the end of July. He said the process would require sustained ministerial involvement since "high level officials" appear unable to make key decisions.
¶10. (SBU) Ambassador provided Hugueney with information pertaining to submission of the U.S. revised services offer (ref B). Hugueney described the Brazilian revised services offer, which will be tabled later in the week, as a major improvement, including such sectors as financial, telecommunications, engineering, maritime services, among others. As in the past, he cautioned that Brazil's ability to be forthcoming in services and industrial products (NAMA) negotiations will depend on advances in the agricultural talks.
¶11. (SBU) Hugueney is slated to leave his post as Brazil's chief capital-based WTO negotiator to take up the post of Brazilian Ambassador to the WTO. His nomination is tentatively scheduled to go before the Senate Foreign Affairs Committee the week of June 13 before being forwarded for a plenary vote. If all goes smoothly, Ambassador Hugueney plans to take up his post in Geneva in late August or early September. U.S.-Brazil Soybean Discussions
¶12. (SBU) Due to his Senate confirmation hearings, Ambassador Hugueney will not attend the June 16 bilateral discussions in Washington on soybean support. The Brazilian delegation will be led by Elisabeth Serodio, Secretary of International Affairs in the Ministry of Agriculture; other participants include Flavio Damico (Itamaraty Agriculture and Basic Products Division), and representatives of ICONE (Institute for International Trade Negotiations) as well as the private sector. Hugueney described the upcoming Washington session as a great opportunity for both sides to clear the air on soybean subsidies, and appeared upbeat on the chances for success of the talks. Iraq Conference
¶13. (SBU) Ambassador delivered Ref C demarche on the June 21-22 US-EU International Conference on Iraq in Brussels. Hugueney confirmed Brazil's plan to attend and assured Ambassador the GoB would take into consideration the points of the demarche. Comment
¶14. (C) We are encouraging the U.S. pharmaceutical companies to explore working with CNI on a strategy for better informing the Brazilian Congress about the potential negative consequences of both compulsory licensing and exempting AIDS drugs from patent coverage. However, as Hugueney's comments testify, the debate over patent protection for AIDS drugs is highly political, complicating the GoB's ability to manage the issue as well as the Mission's ability to engage the key GoB decision-makers, which appear to be in the Presidency. (Indeed, the Abbott representative told us that according to his contacts, the impetus for licensing is coming from President Lula himself; a high-level delegation from the company may seek an appointment directly with the president on this issue.) And notwithstanding assurances by Presidential Chief of Staff Jose Dirceu that he would consult with Mission concerning any compulsory licensing decision (ref D), Post believes that at any moment political forces could align so as to prompt precipitous action by the GoB.
¶15. (C) Post understands that USTR is reviewing legal implications for Brazil's international obligations of both potential compulsory licensing and eventual passage of the patent legislation; Washington may want to start considering a range of potential reactions, bearing in mind that allies on this issue do exist within the GoB. We would welcome guidance on the process/procedures the GoB would have to follow should it decide to go the compulsory licensing route. It is ironic that this potential clash on patent rights comes just as cooperation by the GoB in the area of copyright enforcement is finally showing substantial improvement. Danilovich